|
CCDC99 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.809200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.458300E-02 |
| Normal-vs-Stage2 |
1.699400E-01 |
| Normal-vs-Stage3 |
1.023080E-03 |
| Normal-vs-Stage4 |
1.633040E-01 |
| Stage1-vs-Stage2 |
5.842600E-01 |
| Stage1-vs-Stage3 |
6.297400E-03 |
| Stage1-vs-Stage4 |
2.054000E-01 |
| Stage2-vs-Stage3 |
3.949900E-02 |
| Stage2-vs-Stage4 |
2.324800E-01 |
| Stage3-vs-Stage4 |
4.653600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.900790E-03 |
| Normal-vs-AfricanAmerican |
6.013800E-02 |
| Normal-vs-Asian |
7.193600E-02 |
| Caucasian-vs-AfricanAmerican |
4.383000E-01 |
| Caucasian-vs-Asian |
2.288800E-01 |
| AfricanAmerican-vs-Asian |
6.428500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.525730E-02 |
| Normal-vs-Female |
4.09300000000501E-05 |
| Male-vs-Female |
2.817800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.373800E-02 |
| Normal-vs-Extreme_Weight |
1.156200E-01 |
| Normal-vs-Obese |
4.263000E-03 |
| Normal-vs-Extreme_Obese |
7.754800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.154000E-01 |
| Normal_Weight-vs-Obese |
5.735800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.404610E-01 |
| Extreme_Weight-vs-Obese |
8.724300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.507800E-01 |
| Obese-vs-Extreme_Obese |
2.027000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.599200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.630100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.636380E-01 |
| Normal-vs-Age(81-100Yrs) |
2.916400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.313200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.211800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.184100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.879000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.967800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.289800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.841500E-02 |
| Normal-VS-Type2 PRCC |
6.045900E-02 |
| Normal-VS-KIRP CIMP |
5.500100E-03 |
| Normal-VS-Unclassified PRCC |
3.564700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.714000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.164400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.794300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.271010E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.082200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.435670E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.217800E-02 |
| Normal-vs-N1 |
6.221200E-03 |
| Normal-vs-N2 |
5.639400E-01 |
| N0-vs-N1 |
2.447700E-02 |
| N0-vs-N2 |
9.081800E-01 |
| N1-vs-N2 |
3.199800E-01 |
|
|
